Phase I Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2026-10-15
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the tolerability, reactogenicity and safety of 2 injections (approximately 2 months apart) of three different dose levels of ABO1108 in adults aged 40 years or above.